Local Application of Hyaluronic Acid (HYADENT BG) With Free Soft Tissue Grafing Improves Treatment Outcomes.
Launched by JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Mar 27, 2021
Trial Information
Current as of April 28, 2025
Completed
Keywords
ClinConnect Summary
The study was approved in the Institutional Review Board (IRB) at Jordan University for Science and Technology and Jordanian Food and Drug Administration. This clinical trial was a single-centre, parallel-group, prospective, randomized, subject-blind placebo-controlled study of Hyaluronic Acid (HYADENT BG), and placebo in patients undergoing FGG who met the inclusion criteria. The study was performed in accordance with the International Conference on Harmonization Good Clinical Practice and CONSORT guidelines.For all patients included in the study, phase I periodontal therapy was completed ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy
- • non-smoker,
- • not taking any medication
- Exclusion Criteria:
- • Pregnant
- • lactating women
- • gingival pigmentation
- • previous periodontal surgery
About Jordan University Of Science And Technology
Jordan University of Science and Technology (JUST) is a leading academic institution dedicated to advancing research and innovation in the fields of science and technology. Committed to fostering a culture of excellence, JUST actively engages in clinical trials aimed at improving health outcomes and contributing to the medical community's knowledge base. With a robust framework for ethical research practices, the university collaborates with local and international partners to explore innovative solutions to pressing health challenges, thereby enhancing patient care and promoting scientific discovery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Irbid, , Jordan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials